Key result
This biographical article details the career of Finn Waagstein, a pioneer in the evolution of beta-blocker therapy for the treatment of heart failure.
Biographical note on Finn Waagstein, a pioneer in the use of beta-blockers for heart failure.
Recalls foundational beta-blocker insights in HF; extends historical context without new clinical evidence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Waagstein et al. (2017) studied Heart failure. β-Blockers was evaluated. This biographical article details the career of Finn Waagstein, a pioneer in the evolution of beta-blocker therapy for the treatment of heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: